National Pension Service Has $170.19 Million Stock Position in CME Group Inc. $CME

National Pension Service increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 4.4% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 770,671 shares of the financial services provider’s stock after buying an additional 32,769 shares during the quarter. National Pension Service owned 0.21% of CME Group worth $170,187,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Northwestern Mutual Investment Management Company LLC lifted its holdings in shares of CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after acquiring an additional 37 shares during the last quarter. Rehmann Capital Advisory Group grew its holdings in shares of CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares during the last quarter. Endowment Wealth Management Inc. grew its holdings in shares of CME Group by 4.4% during the 4th quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the last quarter. NBT Bank N A NY increased its position in CME Group by 2.3% during the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after purchasing an additional 38 shares in the last quarter. Finally, Resonant Capital Advisors LLC increased its position in CME Group by 3.8% during the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 39 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other CME Group news, Director William Shepard purchased 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the acquisition, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.2%

Shares of NASDAQ CME opened at $274.07 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The firm has a 50 day moving average price of $262.78 and a two-hundred day moving average price of $277.43. The stock has a market cap of $98.55 billion, a P/E ratio of 23.25, a price-to-earnings-growth ratio of 3.25 and a beta of 0.24.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. CME Group’s revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.96 earnings per share. As a group, equities analysts forecast that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio is currently 44.11%.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: New Treasury clearing platform could expand revenue opportunities. CME Group plans to launch CME Securities Clearing on December 7, ahead of an SEC mandate requiring central clearing for certain U.S. Treasury transactions. The service is intended to provide additional clearing capacity, customer choice and capital efficiency, potentially allowing CME to capture new clearing volumes and strengthen its position in the Treasury market. CME Group to Launch CME Securities Clearing
• Positive Sentiment: Shareholder payout remains a support. CME’s approximately $467 million dividend payment, scheduled for September 25, reinforces the company’s strong cash-generation profile and may appeal to income-focused investors. CME Group’s $467 Million Dividend
• Neutral Sentiment: Planned management transition appears orderly. CME named insider Jack Tobin as CFO, succeeding Lynne Fitzpatrick, who is expected to become CEO in March 2027. Internal promotions can reduce succession risk, although investors may monitor execution during the transition. CME Group names Jack Tobin as CFO
• Neutral Sentiment: Market volatility could support trading activity. Conflicting Federal Reserve and Treasury policy signals may increase interest-rate and bond-market volatility, which can lift demand for CME’s hedging products, but also add uncertainty around the economic outlook. Fed and Treasury at Odds
• Negative Sentiment: Regulatory litigation remains an overhang. An amicus brief urged dismissal of CME’s lawsuit against the CFTC concerning Hyperliquid, highlighting continued uncertainty around the exchange’s regulatory disputes and digital-asset ambitions. Hyperliquid Policy Center Files Amicus Brief

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Barclays cut their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 9th. Morgan Stanley upped their price target on shares of CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a report on Thursday, July 23rd. Weiss Ratings cut CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Raymond James Financial reissued an “outperform” rating and set a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. Finally, Bank of America boosted their price objective on CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research report on Thursday, July 23rd. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $289.75.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for a broad range of financial and commodity products. Its exchange platforms enable participants to manage risk, discover prices and gain exposure to asset classes including interest rates, equity indexes, foreign exchange, energy, metals, agricultural commodities and digital assets.

The company’s principal marketplaces include CME, CBOT, NYMEX and COMEX. Products are offered through futures and options contracts, with electronic trading available through CME Globex as well as exchange-based and privately negotiated transactions.